Clinical Trial Update: A Phase I Study Of Thymoglobulin In Patients With Relapsed Or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase I study evaluating thymoglobulin in patients with relapsed or refractory multiple myeloma; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Relapsed Or Refractory Multiple Myeloma | Phase 1 | Status: COMPLETED